157 related articles for article (PubMed ID: 38009017)
1. Effect of interleukin-12 gene expression on insulin resistance in patients with acne vulgaris.
AbdElneam AI; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Alantry AK; Atef LM
Skin Res Technol; 2023 Nov; 29(11):e13503. PubMed ID: 38009017
[TBL] [Abstract][Full Text] [Related]
2. In severe acne vulgaris, TNF-α gene variants are connected to increased TNF-α gene expression and insulin resistance.
AbdElneam AI; Alhajlah S; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Alantry AK; Atef LM
Skin Res Technol; 2024 Jul; 30(7):e13811. PubMed ID: 38923681
[TBL] [Abstract][Full Text] [Related]
3. Apo B-48 gene expression and low-density lipoprotein as a factor for increased insulin resistance and severity of acne.
AbdElneam AI; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Atef LM
Gene; 2023 Nov; 885():147703. PubMed ID: 37572798
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum desnutrin levels in patients with acne vulgaris.
Demir B; Ucak H; Cicek D; Aydin S; Erden I; Dertlioglu SB
Eur J Dermatol; 2014; 24(5):589-93. PubMed ID: 25152512
[TBL] [Abstract][Full Text] [Related]
5. Serum and salivary adipsin levels and its association with insulin resistance in acne vulgaris patients.
Albalwa K; Kenawy M; El-Fallah AA; Salem RM
J Cosmet Dermatol; 2023 Apr; 22(4):1354-1360. PubMed ID: 36459421
[TBL] [Abstract][Full Text] [Related]
6. Serum Irisin: A Potential Diagnostic Marker for Insulin Resistance in Acne Vulgaris.
Tang L; Yu B; Liao Y; Long S; Yan H; He Q; Li C
Indian J Dermatol; 2022; 67(4):477. PubMed ID: 36578741
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the relationship between insulin resistance and visceral adiposity index in patients with acne vulgaris.
Kaya İFK; Eryılmaz MA; Pekgör O; Külahçı E
Turk J Med Sci; 2022 Apr; 52(2):477-483. PubMed ID: 36161627
[TBL] [Abstract][Full Text] [Related]
8. Incretin serum level as a biomarker of insulin resistance in acne vulgaris patients.
Khattab FM; Fawzy M
J Cosmet Dermatol; 2022 Oct; 21(10):5181-5186. PubMed ID: 35478371
[TBL] [Abstract][Full Text] [Related]
9. Insulin Resistance in Patients with Acne Vulgaris.
Gruszczyńska M; Sadowska-Przytocka A; Szybiak W; Więckowska B; Lacka K
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626790
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in moderate to severe acne vulgaris.
Singh M; Shri D
Indian J Dermatol; 2022; 67(2):205. PubMed ID: 36092205
[TBL] [Abstract][Full Text] [Related]
11. The effect of isotretinoin on insulin resistance and adipocytokine levels in acne vulgaris patients.
Soyuduru G; Ösoy Adışen E; Kadıoğlu Özer İ; Aksakal AB
Turk J Med Sci; 2019 Feb; 49(1):238-244. PubMed ID: 30761880
[TBL] [Abstract][Full Text] [Related]
12. Tissue expression of IL-17A and FOXP3 in acne vulgaris patients.
Farag AGA; Maraee AH; Rifaat Al-Sharaky D; Elshaib ME; Kohla MSM; Shehata WA
J Cosmet Dermatol; 2021 Jan; 20(1):330-337. PubMed ID: 32413182
[TBL] [Abstract][Full Text] [Related]
13. Interleukin19 gene polymorphism and its serum level in acne vulgaris patients.
Bazid H; Marae A; Tayel N; Sleem R; Mahrous E; Mostafa MI; El Gayed EMA
J Immunoassay Immunochem; 2022 Jan; 43(1):1951291. PubMed ID: 34292139
[TBL] [Abstract][Full Text] [Related]
14. Association between isolated female acne and insulin resistance: a prospective study.
Kartal D; Yildiz H; Ertas R; Borlu M; Utas S
G Ital Dermatol Venereol; 2016 Aug; 151(4):353-7. PubMed ID: 26373866
[TBL] [Abstract][Full Text] [Related]
15. Association of interleukin-6 gene promoter polymorphism with acne vulgaris and its severity.
Ragab M; Hassan EM; Elneily D; Fathallah N
Clin Exp Dermatol; 2019 Aug; 44(6):637-642. PubMed ID: 30652337
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum levels of interleukins 1-beta, 10 and 12 in patients with acne vulgaris.
Mohamed M; Shehata HAA; Fahmy NF; Saleh R
J Cosmet Dermatol; 2022 Dec; 21(12):7100-7106. PubMed ID: 36125396
[TBL] [Abstract][Full Text] [Related]
17. Serum Interleukin-19 Levels in Acne Vulgaris Patients of Varying Clinical Severity in Erbil City.
Mohammed HM; Qurtas DS; Meran AD
Cureus; 2023 Nov; 15(11):e48939. PubMed ID: 38106772
[TBL] [Abstract][Full Text] [Related]
18. Assessment of serum interleukin-19 in acne vulgaris patients of different clinical severities.
Saleh HM; Deif MA; El-Husseiny RM
J Cosmet Dermatol; 2021 Sep; 20(9):3034-3040. PubMed ID: 33538078
[TBL] [Abstract][Full Text] [Related]
19. Environmental, inflammatory, and anti-inflammatory squad in acne vulgaris pathogenesis: AhR, IL-36, and IL-38.
Mohamed El Esawy F; Ali Mohammed S; Nasar Zargon Nasar E; Hemdan Mostafa S; Elhabak DM
J Cosmet Dermatol; 2022 Jul; 21(7):3038-3045. PubMed ID: 34679236
[TBL] [Abstract][Full Text] [Related]
20. Dietary glycemic factors, insulin resistance, and adiponectin levels in acne vulgaris.
Çerman AA; Aktaş E; Altunay İK; Arıcı JE; Tulunay A; Ozturk FY
J Am Acad Dermatol; 2016 Jul; 75(1):155-62. PubMed ID: 27061046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
